Taipei, Taiwan

Lo Chang


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lo Chang: Innovator in Pharmaceutical Compositions for Joint Pain

Introduction

Lo Chang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of joint pain. His innovative approach has led to the development of a unique pharmaceutical composition that addresses this common ailment.

Latest Patents

Lo Chang holds 1 patent for his invention titled "Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain." This patent describes a pharmaceutical composition that includes a lipid mixture comprising one or more phospholipids and an effective amount of a therapeutic agent or a pharmaceutically acceptable salt. The total amount of phospholipids in the composition ranges from about 20 mM to about 150 mM, with an optional range of 70 mM to 110 mM. The composition is designed for use in the treatment of joint pain through articular injection.

Career Highlights

Throughout his career, Lo Chang has worked with prominent companies in the pharmaceutical industry. He has been associated with Taiwan Liposome Company, Ltd. and Tlc Biopharmaceuticals, Inc. His work in these organizations has allowed him to further develop his expertise and contribute to advancements in pharmaceutical technologies.

Collaborations

Lo Chang has collaborated with esteemed colleagues in his field, including Yun-Long Tseng and Sheue-Fang Shih. These partnerships have facilitated the exchange of ideas and fostered innovation in the development of effective treatments for joint pain.

Conclusion

Lo Chang's contributions to pharmaceutical compositions for joint pain highlight his innovative spirit and dedication to improving patient care. His work continues to influence the field and offers hope for those suffering from joint-related issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…